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Through their long history of public service, diverse microbial Biological Resource Centres (mBRCs) have made
myriad contributions to society and science. They have enabled the maintenance of specimens isolated before
antibiotics, made available strains showing the development and change of pathogenicity toward animals, humans
and plants, and have maintained and provided reference strains to ensure quality and reproducibility of science.
However, this has not been achieved without considerable financial commitment. Different collections have unique
histories and their support is often tied to their origins. However many collections have grown to serve large
constituencies and need to develop novel funding mechanisms. Moreover, several international initiatives have
described mBRCs as a factor in economic development and have led to the increased professionalism among mBRCs.
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The provision of microbial resources for research is now
recognised as being an essential component in the ad-
vancement of the life sciences. The Organisation for
Economic Cooperation and Development (OECD) estab-
lished the concept of Biological Resource Centre (BRC)
and stressed their importance in the developing bioecon-
omy. The general concept of a BRC presented at that
time includes service providers and repositories of the
living cells, genomes of organisms, and information re-
lating to heredity and the functions of biological sys-
tems. BRCs contain collections of culturable organisms
(i.e. of the four domains of life: micro-organisms, plant,
animal, and human cells), replicable parts of these (e.g.
genomes, plasmids, viruses, cDNAs), viable but not yet
culturable organisms cells and tissues, as well as data
bases containing molecular, physiological and structural
information relevant to these collections and related bio-
informatics (OECD 2007). At the conclusion of the
OECD BRC task force work it was considered advisable
to coordinate development in the four domains* Correspondence: d.smith@cabi.org
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in any medium, provided the original work is pseparately because the organisms were handled very dif-
ferently and because existing collections were embedded
in the different communities they serve. Consequently,
the microbial community followed up this work with the
Global Biological Resource Centre Network demonstra-
tion project (Fritze et al. 2012) which focussed on collec-
tions of living microorganisms. European member states
in the European Strategy Forum for Research Infrastruc-
tures (ESFRI) accepted the pan-European research infra-
structure Microbial Resources Research Infrastructure
(MIRRI) on to their road map for 2010 and its prepara-
tory phase began in late 2012. At a global level, regional
initiatives in the USA, Asia, and South America are un-
derway (Smith 2012). The hypothesis is that the full po-
tential of microbial diversity is yet to be harnessed and a
coordinated approach to resource provision will acceler-
ate innovation and discovery. This paper discusses the
further development and investment needed in the mi-
crobial domain and includes the transition necessary
from the traditional culture collection, holders of labora-
tory based living material, to the next generation micro-
bial resource centres.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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The first public service collection was established by
Professor Frantisek Král in 1890 at the German Uni-
versity of Prague (Uruburu 2003) and some of the
strains first deposited remain available through the
public service collections of today. Shortly after, the
collection of the Institut Pasteur was created by Dr. Binot
in 1891 (see http://www.pasteur.fr/ip/easysite/pasteur/en/
research/collections/crbip/general - informations -concern-
ing-the-collections/iv- the-open-collections/iv-i-collection-
of-institut-pasteur-cip). Some of the earliest fungal mBRCs
include the Mycothèque de l’Université Catholique de
Louvain (MUCL, Belgium) founded in 1892 which cur-
rently holds over 25,000 strains of filamentous and yeast-
like fungi, representing over 3,300 species of Ascomycetes,
Basidiomycetes, Hyphomycetes and Zygomycetes; The
Centraalbureau voor Schimmelcultures (CBS) Fungal Bio-
diversity Centre, founded in 1904 as an institute of the
Royal Netherlands Academy of Arts and Sciences, main-
tains a world-renowned collection of living filamentous
fungi, yeasts and bacteria. Other collections have grown
by consolidation over many years and the CABI culture
collection is an example of this path. While CABI was
founded in 1910, the CABI culture collection has its roots
in the Imperial Bureau of Entomology which was estab-
lished in 1913. This was followed in 1920 by the Imperial
Bureau of Mycology whose dual foci were the identifica-
tion of fungal diseases of plants, animals and humans, and
the abstracting of the mycological literature. Requiring a
collection of reference strains, the collection at the institute
formerly known as the Imperial Mycological Institute
(IMI), Commonwealth Mycological Institute (CMI), Inter-
national Mycological Institute (IMI) and now simply CABI,
was established in 1947 and now holds approximately 30
000 strains.
Over recent years collections have adopted new tech-
nologies to characterise and add value to their holdings.
The Fungal Genetic Stock Center (FGSC) at the University
of Missouri-Kansas City demonstrates this (McCluskey
et al. 2010). The collection, originally founded in 1960 to
preserve mutant strains of Neurospora and Aspergillus
currently holds over 19,000 Neurospora strains including
more than 12,000 Neurospora gene deletion mutants, over
2,000 Aspergillus strains, and various representatives of
other fungal taxa including mating type testers, vegetative
compatibility testers, and strains subject to whole genome
sequence analysis. Additionally, as molecular genetic tech-
nology developed in the 1980’s and 1990’s, the FGSC
added cloned genes, cloning vectors, and gene libraries to
its holdings. In 2003 and 2004, FGSC accepted nearly
50,000 Magnaporthe GMO mutants; in 2005 it began to
distribute arrayed sets of knock-out mutants of Cryptococ-
cus and Candida mutants. The rapid growth holdings atthe FGSC has been associated with growth of strain dis-
tribution of over 100 fold (1,000 to >100,000 total
strains per year).
As the value of microbial germplasm became better
understood (Stern 2004), over 600 service collections have
been established. The register of culture collections at the
World Data Centre for Microorganisms (WDCM) pre-
sents data on almost 650 culture collections world-wide
holding over 2 million strains of microorganisms, mainly
bacteria and fungi. Almost 130 of these are affiliated col-
lections of the World Federation for Culture Collections
(WFCC) and as such they have agreed to operate to
WFCC guidelines (Anon 2010).
The modern day culture collection has had to adapt
to new demands and regulatory requirements and thus
the microbial domain Biological Resource Centre
(mBRC) has evolved. mBRC status is available to those
microbiological resource collections that implement
OECD best practice, network their activities nationally
and internationally for efficiency and effectiveness, meet
mandatory guidance laid down in membership rules,
and carry out research to add value to holdings. Ultim-
ately however, it is nations that assign formal mBRC sta-
tus and while there are many self-declared mBRCs there
is no formal mechanism to recognize this status. Many
collections meet most of the criteria of a formal mBRC,
although many are missing the collaborative, or net-
working elements, the advanced quality control, and the
adherence to international standards and regulations.
This notwithstanding, there is gathering evidence that
mBRCs are contributing to discovery and helping pro-
vide solutions to societal and economic challenges. The
European Consortium for Microbial Resource Centres
(EMbaRC) project (www.embarc.eu) drew together ex-
amples of microbial resource collection success stories
(Smith and Day 2012) that demonstrate the value of pro-
viding products and services directly to bioindustry to help
develop marketable products. The solutions described
cover biocontrol agents to control locusts, phages to con-
trol human disease, microbial enzyme activity to decon-
taminate waste water, improved flavour in alcoholic drinks
and improvements in food contamination detection and
prevention. Such examples of collection to use reveals
how microbial resource collections are playing a role in
addressing the world’s grand challenges by improving our
environment, facilitating food security, and providing
products for healthcare. Similarly, the impact of materials
has been evaluated and some measures demonstrate that
impact is increased more than two fold when materials are
publically available (Furman and Stern 2011). The potential
is enormous if such activities could be enhanced, multiplied
and coordinated through closer relationships between col-
lections and researchers and facilitation of partnerships.
The Microbial Resource Research Infrastructure (MIRRI)
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resources to support research and development and ultim-
ately this aim (www.mirri.org).
The G8 Science Ministers Statement https://www.
gov.uk/government/publications/g8-science-ministers-
statement-london-12-june-2013 made on 12th June
2013 highlighted the need to improve transparency,
consistency and coordination of the global scientific
research enterprise to address global challenges. They
focussed on antimicrobial drug resistance as a major
health security challenge and stressed that research infra-
structures are key elements in research and innovation
policies. MIRRI intends to address these challenges by
working with multidisciplinary partners delivering to them
the resources, tools, and services needed to facilitate the
discovery of solutions. The microbes are the great pio-
neers of our planet surviving the extremes and having
interesting chemistry to provide answers. Examining or-
ganisms from before the introduction of antibiotics and
comparing them with resistant strains provides the obvi-
ous route to improving our understanding and increasing
the opportunity to discover new therapeutic modalities.
Understanding the chemistry and seeking those organisms
with the properties needed, be they taxonomic relatives or
organisms from particular ecosystems, the coordinated ef-
forts of Microbial Resource Centres can accelerate the
process. Well described microbial resources will play a key
role in underpinning the bio-economy and driving eco-
nomic growth. To do this there is the need to better utilise
microbiological diversity in biotechnology. This is funda-
mental to the delivery of the bio-economy and to acceler-
ate the discovery of natural solutions to today’s global
challenges.
The United States Culture Collection Network (USCCN)
is a Research Coordination Network (RCN) for ex situ
Microbial Germplasm Collections sponsored by the US
National Science Foundation (Grant DBI-1203112). The
US Culture Collection Network (www.usccn.org) brings to-
gether scientists working with laboratory based collections
of microbes. The network is holding workshops to teach
best practices for managing, preserving, and distributing
bacteria, fungi, and other microscopic organisms in the
context of formal culture collections. Biosecurity and regu-
latory issues are to be emphasized at workshops. Additional
goals include re-establishing a professional society of cul-
ture collection researchers in the US, developing internet
based collection management tools, and fostering com-
munication between US collections, foreign collections,
and international collection networks. The overall aim
is to ensure that microbial resources are made available
to the scientific community and the culture collections
providing them are supported and sustainable. These
are common goals shared globally and it is important
that lessons learned are shared.Funding systems of mBRCs
The relatively higher requirements associated with mBRC
status come with additional associated costs that mBRCs
must bear. However, the increasing professionalism of
BRCs of every type comes at a time when science spend-
ing is held constant or is actually reducing. The strategy
must therefore be to find cost effective ways to balance
operational costs with income and to improve services
and outputs to attract investment into mBRCs. Firstly, we
need to understand these costs better.
While there is not one model for the operational and fi-
nancial sustainability of mBRCs, we can learn a lot from
the experience of existing culture collections. Recent stud-
ies by the OECD and the EMbaRC project have sum-
marised working models of mBRCs (Smith et al. 2013).
Although culture collections or mBRCs have similar activ-
ities and objectives as repositories and suppliers of living
laboratory based biological materials they can be quite dif-
ferent in size, scope and function. Collections can be based
around an individual researcher or research team on the
other hand they can be large public service collections
with a multitude of structures in between. To be an affili-
ate collection of the WFCC, however, a collection should
not be dependent on one individual, but should have some
long term institutional commitment. A typical culture col-
lection financial plan involves revenues from fees for prod-
ucts or services, research, or service contracts, but most
rely on some form of Governmental or host institutional
funding. Additionally, the mBRC or its host may have op-
portunities for other types of cost recovery activities and
these often revolve around expertise and facilities avail-
able. The degree to which such activities may actually pro-
vide support sufficient to ensure financial sustainability of
an mBRC is unproven. Other kinds of funding sources in-
clude support from industry, grants from agencies that
support research, development of databases and other
tools that compliment the core role of mBRCs, and even
funding from charitable sources, especially those associ-
ated with public health or sustainable development. Evalu-
ating different funding mechanisms through controlled
trials has been proposed and this proposal specifically con-
trasted the scientific method with current expert-panel
based evaluation of funding mechanisms (Azoulay 2012).
Because this requires both coordination and a sufficient
data set for comparison, it is difficult to envision a statis-
tical comparison of mBRC funding mechanisms in the
current funding milieu.Costs of running an mBRC
The Organisation for Economic Co-operation and Develop-
ment (OECD) defined a Biological Resource Centre (BRC)
as the next generation of culture collection and genetic re-
source banks. As such they have both basic costs and the
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ment aspects and improved services and research (Table 1).
All collections need to address three key functions, the
ABC of BRCs, Authentication of strains, Best practice in
preservation and supply, and Confirmation of validity of
the associated information provided. However, the costs
associated with these basic tasks can vary, making it ex-
tremely difficult to get a meaningful estimate of the aver-
age costs of running a mBRC. In the microbial domain,
operational costs very much depend on the type and num-
ber of strains being preserved, maintained and distributed,
the extent of the added value the mBRC provides, and the
number and scope of associated services being provided.
Regional factors such as the cost of living and salary ex-
pectations also impact budget requirements. The cost of
accessioning a strain in a World Federation for Culture
Collections (WFCC) affiliated collection was shown to
vary enormously (Smith 2012); the most expensive quotedTable 1 Collection development
Status of collection Characteristics of collection status
Basic level • Basic methods for Biological material
preservation are available
• Basic documentation level
Intermediate level • Sound facilities
• Good human resources
• Good technologies in place
• Electronic catalogues and data management
• Operating to international criteria
• Wide stakeholders’ involvement
• Involvement into regional/national networking
High level • Sustainable human resource training
in relevant to BRC domains
• Collection quality management is in place
• Intellectual Property Rights regulations, MTAs;
biosafety and biosecurity standards are in place
• Accredited or certified to the operational
and quality levels of the International
Standards Organization or
• Equivalent
• Clear management program and collection’s
strategy in place
• Sustainable fundraising mechanisms
with governmental support
• Raise of public awareness in the domain of
Biological Resources preservation
• Regular monitoring and adjustment of
collection needs
• Leading activity in the regional/national/
international networking
BRC • High quality standards collections
accredited and certified to the OECD standards
• Functioning according to the OECD instrumentswas over €3000 but the average cost is over €350. These
costs depend on the difficulties in handling the organisms,
for example the investment in time in isolating single cells
to remove contamination, and defining optimum growth
conditions. Costs also depend upon the techniques utilized
to preserve the different organisms and the extent to which
they are characterized, for example some collections in-
clude sequencing costs or other methodologies such as
metabolic or protein profiling for checking authenticity
(Smith 2012; Smith et al. 2013) or molecular tools such as
Ribotyping (Kostman et al. 1995) or MALDI-TOF (Matrix
Assisted Laser Desorption/Ionization, Time of Flight) mass
spectroscopy (Lay 2000). Once strains are accessed into the
collection they must be stored indefinitely and costs vary
depending upon the methodology used and the validated
life span of the specimen. While it may cost only a few
cents to store an ampoule in liquid nitrogen for a year, a
collection of 1,000 strains may expect to spend €1.500-
3,750 per year for liquid nitrogen. Larger collections, which
are able to secure lower costs, may incur liquid nitrogen
costs around €15,000 to store a collection of 20,000-30,000
strains. Freeze dried ampoules are more costly to generate
and should be stored at refrigerated temperatures, but their
cost of storage would be less. Distribution of strains de-
pends on the nature of the strain and the format distrib-
uted. Some strains are simply packaged in UN approved
packaging materials and sent by courier other cells may
need to be shipped cold or even frozen on dry ice. Similarly,
some collections send lyophilized ampoules while other
collections re-activate strains and send living cultures.
Staffing a collection is by far the largest cost associated
with running an mBRC. A collection of 5,000 strains grow-
ing at 500 strains per year and supplying 2,000 strains per
year should require at least three members of staff to cope
with the authentication, preservation and distribution. An
additional staff member would be required to cope with
implementing quality standards and adherence to regula-
tions. Moreover, the taxonomic depth of the collection, or
the diversity of these 5,000 strains plays a role in how many
staff are required. If all these strains are metabolically very
similar, fewer staff is needed than if the strains cover a wide
range of physiological diversity, in which case more expert-
ise is required to maintain them. If an identification service
is to be provided then this will have additional staffing
needs and associated costs. Add to this a collection man-
ager/business developer and researchers, the costs rise
quickly. Thus the cost to run a collection with minimal ser-
vices and research capacity (the latter to improve service to
users) may be over €500,000 per year in Europe (Table 2)
but will vary depending upon the national and local finan-
cial conditions.
This cost varies enormously as examples given below
show. CABI Bioservices, which is equivalent to the
CABI mBRC, has running costs of almost €1.1 million
Table 2 Collections’ costs
Cost item Detail Cost per year
(thousand €)
Staff 3-10 staff (number depends upon
















Consumables Ampoules, chemicals, 20
Total 540-730
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bacteria, it authenticates all its strains using DNA se-
quencing (generally the ITS region for fungi, although
to differentiate some genera specific genes are se-
quenced; for bacteria the 16S rRNA). CABI identifies
over 2,000 strains for outside users. It has a reduced
capacity for acquisition of deposits and supplies only a
few hundred strains per year; culture supply amounts to
less than 3% of its revenue. The bulk of its revenue
comes from the identification service, industrial con-
sultancy services and several contract projects (see
below). It has 19 staff and its day to day operations run
on a cost positive basis. However, the maintenance of
the 30,000 strain archive is partially supported by the
CABI member countries and its host institution and
these subsidies cover about 10% of costs.
The situation at the Leibniz-Institut DSMZ–Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmbH
(German Collection of Microorganisms and Cell Cultures)
is not typical of the majority of public collections in Europe.
DSMZ embraces four different kinds of holdings, i.e. pro-
karyotes (Archaea and Bacteria), human and animal cell
lines, plant virus and plant cell cultures within a single in-
stitute with running costs of about €5.6 million per annum
(2011) and a revenue from identification (molecular, che-
motaxonomic and physiological identification, mycoplasma
elimination of cell cultures) and sales of resources of €3.85
million per annum (2011) for these departments. The
DSMZ funding agencies (mainly the ministry for Science
and Technology) permits the DSMZ to reinvest the major-
ity of this income. The section of prokaryotes, yeast and
fungi maintains about 26,000 strains which are curated by 8
scientists and 18 support staff, with annual running costs of
about €2.98 million. About 20,000 microbial strains were
shipped 2011 to national (40%) and international (60%) cus-
tomers. The large number of scientific and technical staff isexplained by the physiologically and phylogenetically highly
diverse nature of resources which span almost all phyla,
and the majority of genera and species of prokaryotes. This
is exemplified by the maintenance of about 1,500 different
growth media. Other microbial collections with less diver-
sity are able to handle large holdings with much fewer
numbers of support personnel.
Conversely, even the lower level of the average cost of
running an mBRC (€542 K) is very high compared to the
budget of the Fungal Genetic Stock Center (FGSC), in
Kansas City, Missouri. As is the case with many mBRCs,
they do not have support for some of the essential func-
tions at the High level described in Table 2, and only mar-
ginally meet the criteria for the intermediate level. For
example, they operate with 2.5 full time people comprising
of 1 full time manager and 1.5 practical curators. In
addition, the director of the FGSC is a full-time faculty
member with no day-to-day responsibilities at the collec-
tion. The FGSC financial model is one based on national
funding and is dictated by the allocated budget which
often fluctuates and the trend, like most parts of the
world, is down. Recently, the funder has changed their ex-
pectations and FGSC can apply for support for up to
$165 K/year (€123 K), including overhead which translates
to about $100 K (€75 K) for salaries and travel. Clearly this
is not enough to sustain the collection and the FGSC and
other NSF supported collections are encouraged to iden-
tify additional sources of financial support including in-
creased user fees. An additional consideration in these
cost comparisons is how the overhead is calculated. For
FGSC the overhead is 50% of the nominal amount of the
grant–if they get $100 K direct costs, the university re-
quires an additional $50 K in overhead. This is expected
to include things like lab and office space, heat/cooling,
power, water, janitorial services, administration and so on.
Some universities and institutions have much higher over-
head, up to 100-150%.
The diversification of activities in the transition from the
‘Culture Collection’ to a microbial domain BRC, or mBRC,
anticipates additional costs to support expansion of quality
management and regulatory compliance. Quality manage-
ment and quality control are the basis to create a certified/
accredited BRC. To implement these control systems the
mBRC must follow the OECD general requirements de-
fined in OECD Best Practice Guidelines for Biological Re-
source Centres (OECD 2007) combined with their national
legislation, regulations and policies (e.g. sound facilities, hu-
man resources necessary to operate, preservation technolo-
gies in place; e-catalogue and data management, operating
following national and international criteria including Intel-
lectual Property Rights (IPR) regulations, material transfer
agreements to formalise exchange of materials, biosafety
and biosecurity standards, etc.). There have been over 20
collections (Table 3) that have become certified or fully/
Table 3 Accreditated mBRCs
Acronym Name Country Standard
ATCC American type culture collection USA ISO9001:2008; ISO 17025:2005; ISO Guide 34:2009
BIOCEN (BioCC) Centro Nacional de Biopreparados Cuba ISO 9001:2000
CABI CABI Genetic Resource Collection UK Part ISO17025
CCCM Czech Culture Collection of Microorganisms Czech Republic ISO 9001:2008
CBS Centraalbureau voor Schimmelcultures Netherlands ISO9001:2008
CCOS Culture Collection of Switzerland Switzerland ISO 9001:2008
CCRC Culture Collection and Research Center, FIRDI Taiwan ISO 9001:2000; ISO/IEC 17025:2005
CECT Coleccion Espanola de Cultivos Tipo Spain ISO9001:2008
CRBIP Collection de l’Institut Pasteur France ISO9001:2008
DSMZ Leibniz-Institut DSMZ-Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH
Germany ISO9001:2008
ICLC Interlab Cell Line Collection Italy GMP
IFM Quality Services Pty Ltd Australia ISO/IEC 17025; ISO/IEC17043
IHEM Institute of Hygiene and Epidemiology, Mycology Belgium ISO 9001:2008; ISO/IEC 17025:2005
LMBP Department of Biomedical Molecular Biology
Ghent University Plasmid collection
Belgium ISO9001:2008
LMG University of Gent Belgium ISO9001:2008
MUCL Mycology, University Louvain la Neuve Belgium ISO9001:2008
MUM Micoteca da Universidade do Minho Portugal ISO9001:2008
NBRC NITE Biological Resource Center Japan ISO9001:2001
NCIMB National Collection of Industrial, Food, Marine Bacteria UK ISO9001:2000
NCPV National Collection of Pathogenic Viruses UK ISO 9001:2008
NCTC National Collection of Type Cultures UK ISO 9001:2008
NCYC National Collection of Yeast Cultures UK ISO 9001:2008
VTT VTT Technical Research Centre of Finland Culture Collection Finland ISO 9001:2008
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Biological Resource Centre Network (GBRCN) demonstra-
tion project have indicated these costs in their particular
situation (Fritze et al. 2012). MIRRI are taking such costs
into consideration in the development of their business
plan and estimate average costs to be in the order of €60 K
for culture collections to become certified or accredited; al-
though some small collections have been able to put in
place ISO 9001 series certification for a cost in the order of
€18 K. Few collections, or parts thereof, have become
accredited; usually standards such as ISO 17025:2005 are
limited to certain procedures or services rather than applied
to all operations.
To ensure materials provided by the mBRC are authen-
tic, processes must be under review to keep pace with tax-
onomy and advanced technology applications. These areas
are under constant revision in order to increase the cap-
acity to modify classification systems or identify new ele-
ments of biodiversity. mBRCs need investment in new
technologies and human resources development to equip
individuals with understanding, provide skills, access to in-
formation, knowledge and training that will enable them
to perform their activities effectively. Consequently mBRCs
must have sound operational financial plans to survive andto be independently sustainable. Part of the requirement of
being a public service collection and of becoming an mBRC
is that there is a back-up plan to ensure continuity of access
to biological material used in research, deposited under
confidential circumstances, or as part of publication of a
patent. Thus, it is essential that the mBRCs have robust
business plans for the long-term.
Culture collection business plans
The financial challenge of developing Biological Resource
Centres was recognized in the OECD’s report entitled Bio-
logical Resource Centres–Underpinning the Future of Life
Sciences and Biotechnology (OECD 2001). This report made
several recommendations encouraging co-ordination of ac-
tivities among collections in response to the needs of the
users of the microbial resources. It directed Governments
to provide a baseline of long-term core funding to centres
that qualify as BRCs to encourage high standards of quality
and to promote research, development, new technology
and commercial exploitation. To support the development
of financial plans, the OECD suggested that various founda-
tions and philanthropic or charitable organizations should
be asked to extend the level of support given to BRCs. It
was also considered appropriate to develop marketable
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regulatory demands, and for sale to specialized customers,
as long as they do not divert capacity from the core activ-
ities of BRCs. It was recognised that industry can play a part
and should be persuaded to take a long-term view of their
interests and to offer core support for BRCs, either through
funding or through direct participation in the functioning
of BRCs, provided the latter maintain their independence.
Additionally, efforts to harmonize fee structures should be
made in situations where fees are usually charged and to
see that charges are affordable for users.
A workshop on Financial Aspects of BRC’s organised
by the OECD Biological Resource Centres Task Force,
Focus Group III in Genoa, 26 March 2003 identified typ-
ical income streams (Table 4). Some of these income
streams are those that support existing models of culture
collections whereas others represent activities in which
most BRCs are still exploring and may participate in that
may generate recoverable income from stakeholders.
However, it is debatable whether all these activities
have a market and offer worthwhile returns. Often ser-
vices are offered by specialist organisations and the mar-
ket access can be very competitive.
The EMbaRC project examined sustainability of mBRCs
comparing the revenue lines of the partner collections
(Table 5). These collections are in the main well-established
public service collections with a long history of providing
products and services. They show that they have common
products and services but the balance on how important
each individual line is to each collection is significantly
different.
The level of public funding was mainly in the range of
65-92% with the exception of CABI, which has noTable 4 Support for mBRCs
Government support H
D
Private industrial support for participation in the functioning of BRCs O
Private industrial support for internal restricted BRC activities N
Public and private foundation support T
Public fundraising N
Sale of biological resources and technical materials M
O
Provision of specialist services and technical consulting expertise 3
Research income (grants and contracts) T
t
Fees for repository service
(safe deposits and patented strain maintenance)
1
Provision of technical courses 2
Exploitation of and adding value to genetic resources R
Provision of DNA, cDNA libraries, genomic libraries,
filter sets, clones, plates, PCR products, RNAi resources
O
Data storage and retrieval, data mining tools A
Data sourced 6 November 2013 from http://www.wfcc.info/ccinfo/statistics/.specific national funding for the collection; overall
CABI has a member country contribution of around 3%
(97% self-sufficient) and it invests in the collection
maintenance activity. In general for the EMbaRC collec-
tions other sources of funding for 2009 were varied and
are shown in Table 6 and Figure 1.
Commercialisation
There is a requirement for adequate funding to support
culture collections not only their continued maintenance
but also their future development (OECD 2007). Trad-
itional products must be complimented by the accession of
new products to meet the needs of new users. Many collec-
tions are preparing DNA, enzymes, metabolites and other
derivatives from authenticated strains, or curated databases
linked to genome sequence either as standard inventory, or
on a case-by-case basis. Collections can move beyond their
historical context by developing commercial products
through the provision of biotechnological solutions, active
compounds and funding it through public/private invest-
ment and establishing spin off companies.
CABI has been moving in this direction since the 1990’s
after direct UK Government funding ceased. For example,
CABI identified the need for a rapid test kit to detect fungal
contamination in kerosene because available detection
methods of the time took as many as 3-10 days. The com-
pany Conidia Bioscience (http://www.conidia.com) was
established to develop the FUELSTAT™ detection kit that is
changing paradigms for detection of contaminants in fuel.
The use of the FUELSTAT™ kit is recommended in the
Boeing Aircraft Maintenance Manual demonstrating that
it is not beyond culture collection staff to come up with
solutions to current microbial problems and establishalf the collections (over 300) listed by the World
ata Centre for Microorganisms receive such support
nly 22 WDCM registered collections are supported by industry
ormally through bilateral contracts
here are 40 collections that are privately supported
ot many collections are exploiting this route
ost public service collections charge a supply fee;
ften subsidised for the research community
30 collections deliver identification services and 284 provide consultancy
his varies from collection to collection and is dependent on
he availability of researchers
00 collections receive patent deposits and 289 offer storage services
83 WDCM registered collections offer training
arely done by the collections
nly a small number of collections offer these as regular services
specialist set of skills offered rarely
Table 5 EMbaRC partner collections
Participating mBRCs Country
Institut National de la Recherche Agronomique (INRA) France
Institut Pasteur (IP) France
Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) Germany
CAB International (CABI) UK
Universitat de València (UVEG), Colección Española de Cultivos Tipo (CECT) Spain
Universidade do Minho, Uminho-MUM Portugal
Koninklijke Nederlandse Akademie Van Wetenschappen, Centraalbureau voor Schimmelcultures (CBS) The Netherlands
BCCM Laboratorium voor Microbiologie (LMG), Universiteit Gent (UGent) Belgium
BCCM Mycothèque de l’Université catholique de Louvain (MUCL) Belgium
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biosystematics, biological collections and fundamental
research.
CABI has also been involved in developing biocontrol
agents and one particular success, in collaboration with
partners, has been Green Muscle a product used for con-
trol of African Locust (Lomer et al. 2001). The profits
from the sale of this product go into a fund to support
biodiversity initiatives in Africa.
Developing business plans
There are a number of ways mBRCs can develop their
individual business plans. However, it is crucial that they
do not become commercial entities; they must not com-
promise their public service role. With this caveat, some
avenues that can be explored are outlined below. The
collection must clearly define the range of products and
services it can provide with the resources and expertise
it has. These are outlined above as income streams. For
example the mBRC might support governments to co-
ordinate legitimate access to high quality resources for
research and development and also to implement inter-
national conventions and legislation particularly in biose-
curity and in regards to the Nagoya Protocol on Access
and Benefit Sharing. Similarly, mBRCs may also support
bio-industry, researchers and biotechnology by focussing
essential services such as identification of novel organisms,Table 6 Microbial collections’ funding scheme
Category of funding Amount of funding
Maintenance & bench fees 0% to 16%
Resource supply 2% to 75%
Resource deposit 0% to 10%
Services 0% to 39%
Technical training 0% to 1%
Consulting 0% to 7%
Research/public contracts 0% to 94%
Research/private companies 0% to 14%targeting specific chemistry in organisms for further study
and protection of public investment made in the isolation
of organisms and the generation of information and know-
ledge by maintaining the link between the biological ma-
terial and the information, and by being the honest broker
in the conservation and utilisation of genetic resources.
The mBRC needs to understand the global and local mar-
ket and seek information on whom and where their clien-
tele are. There are over 650 collections listed in the World
Data Centre for Microorganisms (WDCM) with over 2 mil-
lion strains but there are gaps for example only 25.5% of
types of the 100,000 fungal species described are available
whereas there is 80% coverage of the types of 9,000 species
of prokaryotes. Stackebrandt reported that of 20,200 pro-
karyotic research strains in 835 articles in eight European
journals in 2008 only 190 strains (0.94%) were deposited in
public service collections (Stackebrandt 2010). There is
much work to do and focussing on the gaps can give an
mBRC an advantage in the market. It is estimated that
around half of a million strains are supplied each year by
the collections registered in the WDCM. If 99% of strains
supplied are not from collections then 50 million strains
are exchanged often without provenance. While there is no
quantitative estimate of the cost, in terms of misidentifica-
tion, or the loss of indirect benefits, there is clearly a need
for mBRCs to provide authenticated strains under a quality
management system and with robust documentation of
strain provenance. Moreover, there are also the yet to be
described microbes to be considered. For example, there
are 100,000 fungal species described but some estimates
suggest that 1.4 million remain to be described and this gap
is potentially larger for the Bacteria and Archaea. Innovative
ways of addressing this will help mBRCs develop an appro-
priate and potentially successful business plan.
As much as there are opportunities for mBRCs to ad-
dress, some of these come with associated risks and cul-
ture collections should balance the risk to established
resources with the potential benefit of expanding into
new areas. For example, in many areas there is pressure
to consolidate resources into infrastructure level
Figure 1 Schematic display of funding sources for EMbaRC partner collections.
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expressed in terms of shared overhead, there is the op-
portunity for significant risk to impact established col-
lections of materials. Chief among these risks is the loss
of expertise associated with historical collections and this
is usually expressed as an erosion in training of microbial
taxonomists. While the number of species remaining to be
characterized still vastly exceeds the number in collec-
tions, there will always be a need for microbial taxono-
mists. Similarly, while strains held in different collections
may have shared historical provenance, their unique his-
tories are important in regard to their status as reference
materials, and even whether they are fit for use. While this
may not have been evident in the pre-molecular era, mo-
lecular techniques are capable of differentiating between
strains that have been otherwise considered equivalent.
More recently, targeted gene sequencing (Wiest et al.
2012) and whole genome sequencing (McCluskey et al.
2011) of Neurospora has allowed unprecedented analysis
of the relatedness of strains with shared lineage. Both of
these examples reflect the research component, mandated
in the OECD guidelines, but impossible in a large consoli-
dated collection.
Other areas where risk needs to be managed include the
investment in novel technologies, the impact of national
and international legislation on exchange of materials (and
information) and the false expectation that organisms will,
in themselves, offer solutions to society’s challenges.
Some of these threats can be mitigated by engagement
of local country authorities and some will depend on the
broad expertise in the interested partners who will take
up the opportunities and reduce impact of threats.
A sound financial plan is needed and funders need identi-
fying and this is different in each country. Engagement at
the Government level is not easy and a lot of work is
needed to engage them. Not only do collections need tofind novel ways of funding but also need to keep abreast
and harness new technologies to produce information on
the strains held, adding value with the aim to provide to-
day’s users with the information they need. It is not always
possible to establish these technologies in house but it is
possible to establish partnerships with manufacturers, other
collections or institutions with the expertise and facilities.
Bioinformatics is of increasing importance to the operation
of collections and new ways of collecting, storing, analysing,
presenting and interrogating information are required to
make best use of biodiversity information. Molecular tech-
niques are increasing in use to differentiate between strains
and in identification. However, work at CABI has shown
through PCR fingerprinting with MR Primer of replicates
of an isolate of Metarhizium anisopliae that after non-
optimised preservation techniques were applied, polymor-
phisms were introduced (Ryan et al. 2002). Therefore at the
very least collections should be adopting such techniques
in their operations to determine if they are preserving
strains without change.
Because most collections will have neither the means,
nor the expertise to deliver materials and services across
the range of microbial resources, networked mBRCs are
the modern generation public service culture collec-
tions. The main drivers for the establishment of net-
works are the need to better utilise biological diversity
in biotechnology to enable nations to deliver the Bioec-
onomy and deliver natural solutions to today’s global
challenges. No single collection can address these chal-
lenges alone.
While a uniform structure of funding is not necessarily
critical, many mBRCs will require a significant compo-
nent of Government funding. Some guarantee of on-
going funding is necessary to ensure that their essential
functions remain reliable for R&D and support of bio-
technology. It is essential that any networking activity
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can work towards the elimination of unnecessary dupli-
cation in holdings but their operational costs must not
impact on the funding of individual member mBRCs. If
the funding for individual collections is reduced the col-
lection is rendered ineffective and can be closed and
thus the network is weakened and undermined.
Strategic implications of operating a mBRC network
In order that a user gets consistent quality and reprodu-
cibility it is a prerequisite for any network that it is built
upon common standards and accreditation. This defines
the network and requires substantial investment. A na-
tional strategy that provides core financial support for a
national mBRC (or mBRCs) reduces the need for exces-
sive central costs. Managing a global network through a
series of national hubs allows mBRCs to meet local re-
quirements but also to take advantage of common ap-
proaches and outputs from the international mBRC
network and provides a mechanism for the network to
be sustainable. Being a network of networks ensures that
the entire network doesn’t collapse if one component
fails. The international mBRC network can be built upon
national initiatives that in turn will evolve from existing
activities. These activities are already based upon a range
of income streams with varying levels of government
support, these must be maintained.
Governments are fundamental partners in the creation
of the national mBRCs and national mBRC networks
that will contribute to the international network, regard-
less of the level of financial support needed. Not all cul-
ture collections will wish to neither become an mBRC
nor participate in networks particularly if this is inappro-
priate to its aims or goals, or if this is not justifiable
given the level of investment required to raise or alter
standards. Links to enable the resources of such centres
to be visible to the user community will need to be cre-
ated with mechanisms to help them supply strains. Gov-
ernments need to recognize that mBRCs will take a
regulated role in the supply and maintenance of danger-
ous or pathogenic organisms. This important core aspect
of mBRCs provides a controlled framework for the avail-
ability of these sensitive resources. In turn, fulfilling this
role requires a level of financial commitment. mBRCs
must use the opportunity of establishing an international
network to seek sponsorship from a variety of new
sources of support (national, international, public, pri-
vate and industry).
A proposed collaborative framework for mBRCs and
long-term financial support
The German Government through Bundesministerium
für Bildung und Forschung (BMBF), the German Federal
Ministry of Research and Education supported a smallSecretariat to draw national efforts together in developing
tools for the establishment of a global network, the Global
Biological Resource Centre Network (GBRCN). Since the
report of these activities (Fritze et al. 2012), national and
regional efforts have been initiated to begin the process of
the establishment of the GBRCN and thus common policy
to enhance microbiological research and improved mecha-
nisms for uptake of quality microbial resources into bio-
technology. The pan-European initiative, the Microbial
Resources Research Infrastructure, furthers efforts and of-
fers mechanisms for improvements in efficiency, sharing
resources and expertise making partner mBRCs more cost
effective (Smith 2012). To extend this to a global scale, it
is envisaged that the GBRCN will be constructed by linking
regional and national efforts. Efficiencies impacting on costs
will be gained through a series of technical sub-groups or
sub-committees to represent each area of technical expert-
ise relevant to the operation of the mBRC network that
would have roles in the standards, operation, quality con-
trol and data aspects of the network. These could include:
 Monitoring accreditation
 Advising organizations on standards
 Reviewing and recommending software packages for
particular applications
 Providing a user interface with the mBRC network
 Providing a link to GBIF, the Global Biodiversity
Information Facility
In order for the infrastructure to be sustainable, mBRCs
need to create a robust management system. It is consid-
ered essential to do this at minimal cost and to avoid the
unnecessary expense of establishing a large stand-alone
secretariat. Once established it may be possible to have a
more ‘virtual’ interaction and data access and exchange.
An Interim Advisory Group may have to be set up prior
to the nomination of the mBRC Management Board to fa-
cilitate the identification of participating organizations and
call on expertise for this task drawn from a range of ap-
propriate disciplines. This group would only exist for the
period leading up to the launch of the project and have a
defined remit, Terms of Reference and life span. MIRRI is
taking up the challenge for Europe and is linked to the
National Science Foundation funded US Culture Collec-
tion Network activities and keeping a watching brief on
developments in Asia, South America and trying to estab-
lish activities with collaborators in Africa.
Conclusion
mBRCs have to take a prominent role in capacity build-
ing and ensure a link between research-based collec-
tions, the mBRC, and the ultimate user. mBRC need to
function as a strategic, national repository for key aca-
demic and industrial research resources, which will in
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ate on the basis of full cost recovery from sales income.
A coordinated approach is necessary to ensure that a na-
tion’s resources are secured for future use. Individual
mBRCs will need to be flexible in their accession policies
to work with others to take in the strains that are de-
scribed in the scientific literature and are isolated or de-
veloped as a result of publicly funded research. In turn,
Governments and funding agency policies must ensure
that the products derived from their research pro-
grammes are deposited in mBRCs as part of the condi-
tions attached to any award. Currently granting agencies
are mandating data sharing and curation plans as part of
any award. This same approach could ensure that micro-
bial resources are preserved and made available. National
funding agencies and mBRCs need to work together to
provide greater support to research based collections in
terms of training and advice on standards, quality control
and integrate more with the national activities in key re-
lated priority research areas (e.g. model organism research
consortia). This requires Governments to provide infra-
structure funding. To ensure that the resources provided
by the individual mBRC are fit for purpose and can be
identified for specific use by biotechnologists, mBRCs
must create partnerships with centres of excellence work-
ing with and developing new technologies to provide the
necessary data. mBRC must also ensure that linkage is
possible to data held in public databases so strain data can
be mined alongside other information sources to facilitate
innovation and discovery. It is also essential the mBRCs
work with the data holders to ensure that the data is sup-
ported by physical resources held in mBRCs to facilitate
validation of information or revisiting materials when new
technologies become available.
It is anticipated that all of these strategic and operational
changes relevant to the national role of mBRCs will en-
hance their position in providing services of benefit to the
scientific community and thus in turn benefit them
by maximizing the potential for financial support. A key
element for discussion, however, remains the degree to
which mBRCs may benefit from the direct commercial ex-
ploitation of the resources that they hold. ‘Ownership’ as a
concept has, to a large degree, been avoided in the past
with the mBRC acting as a ‘Custodian’ of the resource.
Widespread introduction of Material Transfer Agreements
and implications that IPR and reach-through are require-
ments for access to resources would fundamentally alter
the relationship between Depositor, User and the mBRC.
Thus, there is not one financial model that can be ap-
plied to all culture collections, microbial domain BRC or
mBRC. Existing structures suggest that a combination of
governmental, commercial, and project portfolios offers
the best chance for long-term sustainability. The invest-
ment is worth it, particularly if collections network forefficiency and work more closely with users to provide the
resources needed.
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